Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Anixa Biosciences Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 49 | 55 | +6 |
| Shares | 3.93M | 4.42M | +492.5K (+12.5%) |
| Value | $12.8M | $17.2M | +$4.31M (+33.5%) |
New holders (11)
Institutions that held Anixa Biosciences Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laird Norton Trust Company, LLC | 368,835 | $1.43M | 0.17% |
| Jane Street Group, LLC | 43,383 | $168.3K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 14,372 | $55.8K | 0.01% |
| HighTower Advisors, LLC | 13,523 | $52.0K | 0.00% |
| Virtu Financial LLC | 10,973 | $43.0K | 0.00% |
| Marshall Wace, LLP | 10,675 | $41.4K | 0.00% |
| Stephen J. Garry & Associates, LLC | 10,080 | $39.1K | 0.04% |
| Advisory Services Network, LLC | 6,174 | $24.0K | 0.00% |
| Livelsberger Financial Advisory | 1,634 | $6.34K | 0.01% |
| Citigroup Inc | 1,520 | $5.90K | 0.00% |
| Principal Securities, Inc. | 1,000 | $3.88K | 0.00% |
Sold out (5)
Institutions that held Anixa Biosciences Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Bridgeway Capital Management, LLC | 21,000 | $68.7K |
| Squarepoint Ops LLC | 13,514 | $44.2K |
| Renaissance Technologies LLC | 10,000 | $33.0K |
| Adirondack Trust Co | 7,000 | $22.8K |
| Signaturefd, LLC | 57 | $186 |